Daily Management Review

Abbott to spend more than $ 4 billion to buy a competitor


04/14/2017


International pharmaceutical company Abbott Laboratories and provider of diagnostic devices and services Alere Inc. agreed to reduce the amount of the merger transaction to $ 4.4 billion.



Open Grid Scheduler / Grid Engine via flickr
Open Grid Scheduler / Grid Engine via flickr
The deal between the two companies was announced in February 2016. Under the original terms of the agreement, Abbott had to pay $ 56 for each ordinary share of Alere, or $ 5.8 billion in cash. Alere will become Abbott’s division after the deal ends. It is expected that after the transaction will make Abbott the leading provider in the field of diagnostics, and its sales in this segment will exceed $ 7 billion dollars per year.

Later, Alere suggested reducing the transaction value to $ 51 per share due to some internal problems, and Abbott agreed to the offer. These conditions, despite the price reduction, will be favorable for Alere. Thus, the new price represents a significant premium to the value of the company's securities. At the close of trading on Thursday, shares of Alere were worth $ 42.31.

Alere develops and produces rapid tests, including for influenza and streptococcus. The international pharmaceutical company Abbott develops and manufactures products and technologies that cover all areas of health care.

In January, the European Commission approved the deal, provided that Alere sells the unit that manufactures Epoc and Triage blood testing equipment, as well as its business to produce reagents for testing natriuretic peptides (a marker of heart failure).

"Doctors and patients around the world use tests to quickly and accurately identify diseases and monitor health status," said European Commissioner for Competition Margrethe Vestager. "This solution will provide choice and competitive prices in the fast-growing market for small portable test analyzers."

In 2016, the pharmaceutical industry and the medical technology sector completed transactions for $ 500 billion, which is 9% of all transactions in the world. This is stated in an annual review "Annual Review of Global Healthcare" of investment company Arterial Capital Management (ACM) with reference to Dealogic’s data. The amount of transactions with pharmaceutical companies and in the medical technology sector fell by 34% compared to 2015, the average size - $ 383 million versus $ 543 million a year ago, but still it is 10% higher than the average for the last 10 years.

The bulk of the deals came in the industry of pharmaceuticals - $ 297 billion, mainly in North America. The main buyers were strategic investors, that is, the pharmaceutical companies themselves or distributors (86% of transactions).

The largest transaction for 2016 was an agreement on acquisition between Shire and Baxalta, worth more than $ 32 billion. The transaction was closed in June 2016. It is expected that the merged company will become the world's largest in the field of treating patients with rare diseases.

The second, most significant M&A deal of 2016 was AbbVie - Stemcentrx agreement on acquisition for $ 9.8 billion, which was announced in April 2016. The transaction was closed on July 19, 2016. The agreement allowed AbbVie to replenish its product portfolio with a promising candidate for a drugs intended for therapy of small cell lung cancer.

source: bloomberg.com






Science & Technology

Researchers See 'Wannacry' Link As Another Cyber Attack Sweeps Globe

AEON and IBM to create a blockchain platform

Toyota & Cartivator Are Building Flying Cars To Light Up The Olympic Flame Of 2020

Stock trading computers are not a future anymore

Temper Technology With Humanity - Apple's Cook Tells MIT Graduates

As Spying And Crime Tools Mix, Blame Game For Cyber Attacks Grows Murkier

Retailers Could Transform The Market Scenario Into Smart Shopping Experience For The Consumers With The Cloud

A Way To Unlock Wannacry Without Ransom Found By French Researchers

China to introduce face recognition payment system

Clues To Ransomware Worm's Lingering Risks Found By Security Experts

World Politics

World & Politics

Trump to speak for America's dominance in the energy sector

U.S. Official Says Russians Targeted 21 Election Systems

The Britain’s Prime Minister To Bring Down Corporate Tax To Draw More Investments In The Country

Record 65.6 million people were displaced in 2016

Are millionaires preparing for an apocalypse?

EU says goodbye to mobile roaming charges

Denmark loses interest to electric cars

Global Airlines Conference Agenda To Accord Importance To Fresh Safety Concerns